glp-1 slows gastric emptying Nearly half of users discontinue within a year. Not because the medication “failed.” Often because the digestive adjustment wasn't supported. GLP-1s intentionally slow emptying. That shift changes motility patterns. If GLP-1 Gastroparesis: Hidden Dangers Beyond

Keep the vial in its original box or another light-blocking container

doi: 10.1038/s41419-021-04008-9 91

Stable gastric pentadecapeptide BPC 157: novel mediator of Roberts cytoprotection and adaptive cytoprotection. Current Pharmaceutical Design, 20(7), 11261135

Unlike hGH, which carries broader systemic effects and risks associated with elevated IGF-1 levels, AOD9604 appears to selectively promote fat metabolism without triggering growth-related side effects, suggesting its potential as a safer therapeutic candidate for obesity and metabolic disorders [2]

GLP-1 interacts with its receptor to stimulate islet -cells to secrete insulin, inhibit the release of glucagon by islet -cells, increase satiety, and delay gastric emptying in a glucose-dependent manner 284

Antidiabetic drugs with limited evidence for tumor risk association -Glucosidase inhibitors As an antidiabetic drug, -glucosidase inhibitors primarily act by inhibiting the breakdown of complex carbohydrates in the gastrointestinal tract, thereby slowing their absorption and mitigating postprandial hyperglycemia